Clinical Characteristics of Ovarian Cancer Classified by BRCA1, BRCA2 and RAD51C Status
Cunningham, J. M., Cicek, M. S., Larson, N. B., Davila, J., Wang, C., Larson, M. C., Song, H., Dicks, E. M., Harrington, P., Wick, M., Winterhoff, B. J., Hamidi, H., Konecny, G. E., Chien, J., Bibikova, M., Fan, J.-B., Kalli, K. R., Lindor, N. M., Fridley, B. L., Pharoah, P. P. D., Goode, E. L.
Published in Scientific reports (07.02.2014)
Published in Scientific reports (07.02.2014)
Get full text
Journal Article
Elevated CDCP1 predicts poor patient outcome and mediates ovarian clear cell carcinoma by promoting tumor spheroid formation, cell migration and chemoresistance
He, Y, Wu, A C, Harrington, B S, Davies, C M, Wallace, S J, Adams, M N, Palmer, J S, Roche, D K, Hollier, B G, Westbrook, T F, Hamidi, H, Konecny, G E, Winterhoff, B, Chetty, N P, Crandon, A J, Oliveira, N B, Shannon, C M, Tinker, A V, Gilks, C B, Coward, J I, Lumley, J W, Perrin, L C, Armes, J E, Hooper, J D
Published in Oncogene (28.01.2016)
Published in Oncogene (28.01.2016)
Get full text
Journal Article
Activity of the multikinase inhibitor dasatinib against ovarian cancer cells
Konecny, G E, Glas, R, Dering, J, Manivong, K, Qi, J, Finn, R S, Yang, G R, Hong, K-L, Ginther, C, Winterhoff, B, Gao, G, Brugge, J, Slamon, D J
Published in British journal of cancer (17.11.2009)
Published in British journal of cancer (17.11.2009)
Get full text
Journal Article
Results of TRIO-14, a phase II, multicenter, randomized, placebo-controlled trial of carboplatin-paclitaxel versus carboplatin-paclitaxel-ganitumab in newly diagnosed epithelial ovarian cancer
Konecny, G.E., Hendrickson, A.E. Wahner, Davidson, T.M., Winterhoff, B.J., Ma, S., Mahner, S., Sehouli, J., Fasching, P.A., Feisel-Schwickardi, G., Poelcher, M., Roman, L.D., Rody, A., Karlan, B.Y., Mullany, S.A., Chen, H., Ray-Coquard, I.L., Provencher, D.M., Yachnin, A., Cottu, P.H., Glaspy, J.A., Haluska, P., Slamon, D.J.
Published in Gynecologic oncology (01.12.2021)
Published in Gynecologic oncology (01.12.2021)
Get full text
Journal Article
HER2 gene amplification and EGFR expression in a large cohort of surgically staged patients with nonendometrioid (type II) endometrial cancer
Konecny, G E, Santos, L, Winterhoff, B, Hatmal, M, Keeney, G L, Mariani, A, Jones, M, Neuper, C, Thomas, B, Muderspach, L, Riehle, D, Wang, H-J, Dowdy, S, Podratz, K C, Press, M F
Published in British journal of cancer (13.01.2009)
Published in British journal of cancer (13.01.2009)
Get full text
Journal Article
In vitro culture stress due to ambient O2 induces a senescent-like phenotype with abundant DNA repair activity
Rogmann, L, Winterhoff, B, Fredrickson, J, Trejo, T, Meuter, A, Morbeck, M
Published in Fertility and sterility (01.09.2012)
Published in Fertility and sterility (01.09.2012)
Get full text
Journal Article
The dual angiogenesis/metastasis inhibitor PG545 inhibits growth factor-induced cell migration and invasion in vitro and tumor growth in vivo of ovarian cancer cells
Giri, S, Winterhoff, B, Maguire, J, Teoman, A, Dredge, K, Shridhar, V
Published in Gynecologic oncology (01.03.2012)
Published in Gynecologic oncology (01.03.2012)
Get full text
Journal Article
Global gene expression profiling in normal endometrium and endometrial cancer in the same patient using laser capture microdissection can be used for data reduction
Winterhoff, B, Vasmatzis, G, Lima, J. Felipe, Munz, J, Zarei, S, Meuter, A, Murphy, S, Gostout, B
Published in Gynecologic oncology (01.03.2012)
Published in Gynecologic oncology (01.03.2012)
Get full text
Journal Article
Insulin-like growth factor receptor 1 pathway signature correlates with adverse clinical outcome in ovarian cancer
Winterhoff, B, Haluska, P, Kalli, K, Cliby, W, Gostout, B, Oberg, A, Maurer, M, Hartmann, L, Slamon, D, Konecny, G
Published in Gynecologic oncology (01.03.2011)
Published in Gynecologic oncology (01.03.2011)
Get full text
Journal Article
721MO Phase I, two-part, multicenter first-in-human (FIH) study of TORL-1-23: A novel claudin 6 (CLDN6) targeting antibody drug conjugate (ADC) in patient with advanced solid tumors
Konecny, G.E., Hendrickson, A.E. Wahner, Winterhoff, B., Adjei, A.A., Kung, A., Miller, L-L., Press, M.F., Qazi, I., Scholler, N., Dokainish, H., Letrent, S., Slamon, D.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
756P First-in-human phase I study of a novel claudin 6 (CLDN6) targeted antibody drug conjugate (ADC) TORL-1-23
Konecny, G.E., Wahner Hendrickson, A.E., Winterhoff, B., Machado, A., Chander, C., Davenport, S., Bilic, S., Miller, L-L., Chung, A., Press, M.F., Letrent, S., Slamon, D.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
Development of a predictive signatures for immune therapy in ovarian cancer: Whom to treat and whom not to treat?
Talukdar, S., Cepela, J., Chang, Z., Zhang, Y., Mullany, S.A., Nelson, A.C., Starr, T., Winterhoff, B.
Published in Gynecologic oncology (01.10.2020)
Published in Gynecologic oncology (01.10.2020)
Get full text
Journal Article
Age matters when predicting overall survival benefit of combined chemotherapy and radiation versus radiation alone in high risk endometrial cancer: A study of 20,000 women using PORTEC-3 criteria
Casablanca, Y., Tian, C., Powell, M.A., Winterhoff, B., Chan, J.K., Hamilton, C.A., Maxwell, G.L., Darcy, K.M.
Published in Gynecologic oncology (01.10.2020)
Published in Gynecologic oncology (01.10.2020)
Get full text
Journal Article
Gene expression of programmed cell death (PD-1) and its ligand, PD-L1, in primary epithelial ovarian cancer
Talukdar, S., Cepela, J., Chang, Z., Zhang, Y., Grad, A., Mullany, S.A., Starr, T., Winterhoff, B.
Published in Gynecologic oncology (01.06.2019)
Published in Gynecologic oncology (01.06.2019)
Get full text
Journal Article
Single cell analysis of chemotherapy resistance in ovarian cancer
Schefter, A.M., Starr, T., Talukdar, S., Chang, Z., Cepela, J., Shetty, M., Woo, J., Zhang, Y., Baller, J., Nelson, A.C., Wang, J., Winterhoff, B.
Published in Gynecologic oncology (01.10.2020)
Published in Gynecologic oncology (01.10.2020)
Get full text
Journal Article
Identification of clinically relevant genomic alterations in ovarian cancer: A comparison of a focused cancer next generation sequencing (NGS) assay and whole exome sequencing
Thomaier, L., Hagen, J., Henzler, C., LaRue, R., Talukdar, S., Chang, Z., Munro, S.A., Mullany, S.A., Starr, T., Nelson, A.C., Winterhoff, B.
Published in Gynecologic oncology (01.10.2020)
Published in Gynecologic oncology (01.10.2020)
Get full text
Journal Article
Comprehensive single cell analysis of a patient’s primary, recurrent, and xenograft ovarian cancer
Chang, Z., Bedell, S.M., Uppendahl, L.D., Zhang, Y., Grad, A., Wang, J., Mullany, S.A., Nelson, A.C., Starr, T., Winterhoff, B.
Published in Gynecologic oncology (01.06.2019)
Published in Gynecologic oncology (01.06.2019)
Get full text
Journal Article
Single cell RNA-sequencing identifies unique immune cell profiles across metastatic sites in a case of primary ovarian cancer
Schefter, A.M., Uppendahl, L.D., Zhang, Y., Wang, J., Shetty, M., Clark, C., Grad, A., Mullany, S.A., Winterhoff, B., Starr, T.
Published in Gynecologic oncology (01.06.2019)
Published in Gynecologic oncology (01.06.2019)
Get full text
Journal Article
Clinical and Germline Molecular Findings From an Ovarian Cancer Precision Medicine Initiative
Chang, Z., Lee, W., Rivers, Z.T., Uppendahl, L.D., Grad, A., Talukdar, S., Aliferis, C., Jacobson, P., Starr, T., Nelson, A.C., Winterhoff, B.
Published in Gynecologic oncology (01.07.2020)
Published in Gynecologic oncology (01.07.2020)
Get full text
Journal Article
L1 Cell Adhesion Molecule is a Potential Biomarker for Recurrence and Aggressive Endometrial Cancer Subtypes
Moisini, I., Pulver, T., Richter, J., Hellwegg, R., Klein, M., Winterhoff, B.
Published in Gynecologic oncology (01.10.2017)
Published in Gynecologic oncology (01.10.2017)
Get full text
Journal Article